Accrol Group Holdings plc
(“Accrol”)
AIM: ACRL
DIRECTORATE CHANGE
Accrol, the leading independent tissue converter in the UK, announces that, following the appointment of Steve Townsley as Chief Financial Officer on 11 June 2018, Martin Leitch has now stepped down from the Board.
Martin was appointed to the Board as Interim CFO in February 2018 to assist in the early stages of the business turnaround and to allow a search for a permanent CFO to be conducted in an orderly fashion. He will remain with the business for a short period to complete an effective handover.
Dan Wright, Executive Chairman of Accrol, said: “On behalf of the Board, I extend our thanks to Martin for his considerable support and help in progressing the turnaround of the business.”